Sprouty2 Inhibits Migration and Invasion of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis by Down-regulating ATF2 Expression and Phosphorylation

被引:12
|
作者
Zhang, Xing [1 ]
Zhang, Dongmei [2 ]
Wang, Qinyu [1 ]
Guo, Xiaofeng [1 ]
Chen, Jiajia [1 ]
Jiang, Jiawei [1 ]
Li, Mengmeng [2 ]
Liu, Wei [1 ]
Gao, Yingying [3 ]
Zhang, Qi [4 ]
Bao, Guofeng [1 ]
Cui, Zhiming [1 ]
机构
[1] Nantong Univ, Dept Orthoped, Affiliated Hosp 2, 6 Haier Lane North Rd, Nantong 226001, Jiangsu, Peoples R China
[2] Nantong Univ, Med Res Ctr, Affiliated Hosp 2, Nantong 226001, Jiangsu, Peoples R China
[3] Nantong Univ, Dept Rheumatol, Affiliated Hosp 2, Nantong 226001, Jiangsu, Peoples R China
[4] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
rheumatoid arthritis; fibroblast-like synoviocytes; ATF2; SPRY2; ERK MAPK; inflammation; ACTIVATING TRANSCRIPTION FACTOR-2; CELL-PROLIFERATION; PROMOTES; SUPPRESSES; SPRY2; RECEPTOR;
D O I
10.1007/s10753-020-01311-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Activating transcription factor 2(ATF2), a transcription factor belonging to the AP-1 family, plays an important role in inflammation. However, its biological functions and underlying molecular mechanisms in rheumatoid arthritis (RA) remain unclear. Western blot and immunohistochemistry were used to identify the expression of ATF2 and Sprouty2(SPRY2) in RA synovial tissues. SW982 cells were stimulated by TNF-alpha to establish anin vitroRA fibroblast-like synoviocyte (RA-FLS) model. Transwell and monolayer wound-healing were used to detect cell migration and invasion. RNA interference (si-ATF2) and adenovirus vector (Ad-SPRY2) methods were employed to manipulate ATF2 or SPRY2 expression in SW982 cells. The protein expression and phosphorylation levels in SW982 cells were evaluated by western blot. ATF2 expression and phosphorylation were upregulated in the RA synovial tissues. In RA-FLS model, ATF2 expression and phosphorylation were increased in a time-dependent manner. ATF2 knockdown inhibited the migration and invasion of RA-FLS model, reducing the inflammatory factors, which was consistent with the influence on cell behaviors caused by SPRY2 overexpression. Moreover, SPRY2 overexpression inhibited the TNF-alpha-induced phosphorylation of ERK and ATF2 in SW982 cells. The high expression and phosphorylation of ATF2 promoted migration and invasion of RA-FLSs. SPRY2 might inhibited the inflammatory responses of RA-FLSsviasuppressing ERK-ATF2 pathway.
引用
收藏
页码:91 / 103
页数:13
相关论文
共 50 条
  • [1] Sprouty2 Inhibits Migration and Invasion of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis by Down-regulating ATF2 Expression and Phosphorylation
    Xing Zhang
    Dongmei Zhang
    Qinyu Wang
    Xiaofeng Guo
    Jiajia Chen
    Jiawei Jiang
    Mengmeng Li
    Wei Liu
    Yingying Gao
    Qi Zhang
    Guofeng Bao
    Zhiming Cui
    Inflammation, 2021, 44 : 91 - 103
  • [2] Sprouty2 suppresses the inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes through regulating the Raf/ERK and PTEN/AKT signals
    Zhang, Wei
    Du, Zhiyan
    Zhu, Jingying
    Yu, Jiyun
    Xu, Yuanji
    MOLECULAR IMMUNOLOGY, 2015, 67 (02) : 532 - 539
  • [3] Piperlongumine inhibits the proliferation, migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis
    Siqi Xu
    Youjun Xiao
    Shan Zeng
    Yaoyao Zou
    Qian Qiu
    Mingcheng Huang
    Zhongping Zhan
    Liuqin Liang
    Xiuyan Yang
    Hanshi Xu
    Inflammation Research, 2018, 67 : 233 - 243
  • [4] Betulinic acid inhibits the migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis
    Li, Nan
    Gong, Zhaohui
    Li, Xiaojuan
    Ma, Qingyu
    Wu, Mansi
    Liu, Dongdong
    Deng, Lijuan
    Pan, Dongmei
    Liu, Qingping
    Wei, Zhenquan
    Wang, Qiang
    Han, Longyin
    Lin, Changsong
    Chen, Jiaxu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 67 : 186 - 193
  • [5] Indirubin inhibits the migration, invasion, and activation of fibroblast-like synoviocytes from rheumatoid arthritis patients
    Mingcheng Huang
    Lihui Wang
    Shan Zeng
    Qian Qiu
    Yaoyao Zou
    Maohua Shi
    Hanshi Xu
    Liuqin Liang
    Inflammation Research, 2017, 66 : 433 - 440
  • [6] Indirubin inhibits the migration, invasion, and activation of fibroblast-like synoviocytes from rheumatoid arthritis patients
    Huang, Mingcheng
    Wang, Lihui
    Zeng, Shan
    Qiu, Qian
    Zou, Yaoyao
    Shi, Maohua
    Xu, Hanshi
    Liang, Liuqin
    INFLAMMATION RESEARCH, 2017, 66 (05) : 433 - 440
  • [7] Piperlongumine inhibits the proliferation, migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis
    Xu, Siqi
    Xiao, Youjun
    Zeng, Shan
    Zou, Yaoyao
    Qiu, Qian
    Huang, Mingcheng
    Zhan, Zhongping
    Liang, Liuqin
    Yang, Xiuyan
    Xu, Hanshi
    INFLAMMATION RESEARCH, 2018, 67 (03) : 233 - 243
  • [8] Dyrk1A promotes the proliferation, migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis via down-regulating Spry2 and activating the ERK MAPK pathway
    Guo, Xiaofeng
    Zhang, Dongmei
    Zhang, Xing
    Jiang, Jiawei
    Xue, Pengfei
    Wu, Chunshuai
    Zhang, Jinlong
    Jin, Guohua
    Huang, Zhen
    Yang, Jian
    Zhu, Xinhui
    Liu, Wei
    Xu, Guanhua
    Cui, Zhiming
    Bao, Guofeng
    TISSUE & CELL, 2018, 55 : 63 - 70
  • [9] Increased phosphorylation of ezrin is associated with the migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis
    Xiao, Youjun
    Sun, Mengying
    Zhan, Zhongping
    Ye, Yujin
    Huang, Mingcheng
    Zou, Yaoyao
    Liang, Liuqin
    Yang, Xiuyan
    Xu, Hanshi
    RHEUMATOLOGY, 2014, 53 (07) : 1291 - 1300
  • [10] Dexmedetomidine inhibits the invasion, migration, and inflammation of rheumatoid arthritis fibroblast-like synoviocytes by reducing the expression of NLRC5
    Ji, Ya-Ru
    Chen, Yu
    Chen, Yan-Ni
    Qiu, Gao-Lin
    Wen, Jia-Gen
    Zheng, Yan
    Li, Xiao-Feng
    Cheng, Huang
    Li, Yuan-Hai
    Li, Jun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 82